Implementation and outcomes of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) monoclonal antibody treatment program at an academic medical center serving a high-risk patient population.

Borgetti, Scott A; Gross, Alan E; Kottler, Janey; Patel, Kenil; Paek, Jamie; Mena Lora, Alfredo J; Oikle, Diane; Jeffries, Delisa; Radosta, Jon

Borgetti, Scott A; Gross, Alan E; Kottler, Janey; Patel, Kenil; Paek, Jamie; Mena Lora, Alfredo J; Oikle, Diane; Jeffries, Delisa; Radosta, Jon.

Borgetti SA; Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Gross AE; Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, Illinois.
Kottler J; College of Nursing, University of Illinois at Chicago, Chicago, Illinois.
Patel K; Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, Illinois.
Paek J; Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, Illinois.
Mena Lora AJ; Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Oikle D; Ambulatory Services Administration, University of Illinois at Chicago, Chicago, Illinois.
Jeffries D; Ambulatory Services Administration, University of Illinois at Chicago, Chicago, Illinois.
Radosta J; Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.

Antimicrob Steward Healthc Epidemiol ; 1(1): e3, 2021.

Article in English | MEDLINE | ID: covidwho-1860173

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Antimicrob Steward Healthc Epidemiol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google